Currently Viewing:
Newsroom
Currently Reading
Judge Blocks Aetna-Humana Merger on Grounds It Is Anticompetitive
January 23, 2017 – Laura Joszt
Proportion of Minority Patients in ACO Tied to Quality Performance
January 11, 2017 – Laura Joszt
What We're Reading: Drug Makers Take Cautious Approach on Off-Label Promotion
January 02, 2017 – AJMC Staff
What We're Reading: W.Va. Sues Drug Distributors for Fueling the Opioid Epidemic
December 28, 2016 – AJMC Staff
Drug Price-Fixing Charges Result From Investigation of Generic Drug Industry
December 17, 2016 – Laura Joszt
What We're Reading: HHS Extends Deadline for HealthCare.gov 2017 Enrollment
December 16, 2016 – AJMC Staff
What We're Reading: Some Democrats Indicate They May Play Ball on ACA Replacement
December 15, 2016 – AJMC Staff
How Hennepin Health Created a Different Way to Care for People
December 12, 2016 – Laura Joszt
What We're Reading: Joint Initiative Launched to Prevent Physician Suicides
December 02, 2016 – AJMC Staff

Judge Blocks Aetna-Humana Merger on Grounds It Is Anticompetitive

Laura Joszt
The US District Court for the District of Columbia has blocked the Aetna-Humana merger on the grounds it is anticompetitive.
The US District Court for the District of Columbia has blocked the Aetna-Humana merger. According to the decision, the efficiencies gained through the merger would not be enough “to mitigate the anticompetitive effects for consumers in the challenged markets.”

In July 2016, the Department of Justice (DOJ) filed an antitrust lawsuit to prevent both the Aetna-Humana merger and the Anthem-Cigna merger. The DOJ had been concerned that the 2 mergers, which would reduce the market from 5 big insurers to just 3, would lessen competition for individual Medicare Advantage plans and for insurance sold on the individual exchanges. After hearing arguments and reviewing the evidence, the court agrees.

Even the plan to save the merger through Aetna and Humana selling off certain Medicare Advantage assets to Molina Healthcare was not enough to appease the court.

According to the court's decision, new entrants into the market would not be sufficient to replace the competition lost by the merger. In the analysis most favorable to the defendants, there was only a 25.5% chance new entrants would make up for the lost competition, and that number could drop as low as 10%.

"So, even under the most generous of the plausible calculations the median county has a 13.3% chance of experiencing any entry, and a 25.5% chance that this new entry will be sufficient to replace the lost competition," US District Judge John D. Bates, wrote. "There is therefore a relatively small chance overall of replacing the competition lost by the proposed merger."

Aetna's spokesman, TJ Crawford, told Bloomberg that the company is reviewing the opinion and will consider appealing.

More on this story as it develops.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up